BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 1107261
HOUSTON, TX
Position in CRVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$390,621
+$185,031 QoQ
Shares Held
26,700
0.0% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
552,566 | $13,372,097 | |
| 2 | INVA |
Innoviva, Inc.
|
350,253 | $7,954,245 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
791,616 | $6,420,005 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
124,184 | $4,858,078 | |
| 5 | EXEL |
Exelixis, Inc.
|
66,100 | $3,596,501 | |
| 6 | CRMD |
CorMedix Inc.
|
434,132 | $3,407,936 | |
| 7 | KROS |
Keros Therapeutics, Inc.
|
265,017 | $2,835,681 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,794,540 |
All Filings in CRVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $390,621 | 26,700 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $205,590 | 26,700 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $491,579 | 66,700 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $266,800 | 66,700 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $131,334 | 41,300 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $220,955 | 41,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $672,144 | 127,300 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $231,686 | 127,300 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $399,254 | 224,300 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $262,768 | 149,300 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $217,978 | 149,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $250,297 | 109,300 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $144,963 | 159,300 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $135,405 | 159,300 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $130,466 | 159,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $157,707 | 159,300 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $261,252 | 159,300 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $540,563 | 224,300 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $771,012 | 159,300 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $558,831 | 209,300 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $629,244 | 204,300 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $475,972 | 133,700 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $536,137 | 133,700 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $363,664 | 133,700 | Shares | Sole | 2020-08-31 | |
| 2020-03-31 | $282,107 | 133,700 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||